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Abstract
The glutamine/asparagine (Q/N)-rich yeast prion protein Sup35 has a low intrinsic propensity to spontaneously self-
assemble into ordered, b-sheet-rich amyloid fibrils. In yeast cells, de novo formation of Sup35 aggregates is greatly facilitated
by high protein concentrations and the presence of preformed Q/N-rich protein aggregates that template Sup35
polymerization. Here, we have investigated whether aggregation-promoting polyglutamine (polyQ) tracts can stimulate the
de novo formation of ordered Sup35 protein aggregates in the absence of Q/N-rich yeast prions. Fusion proteins with polyQ
tracts of different lengths were produced and their ability to spontaneously self-assemble into amlyloid structures was
analyzed using in vitro and in vivo model systems. We found that Sup35 fusions with pathogenic ($54 glutamines), as
opposed to non-pathogenic (19 glutamines) polyQ tracts efficiently form seeding-competent protein aggregates. Strikingly,
polyQ-mediated de novo assembly of Sup35 protein aggregates in yeast cells was independent of pre-existing Q/N-rich
protein aggregates. This indicates that increasing the content of aggregation-promoting sequences enhances the tendency
of Sup35 to spontaneously self-assemble into insoluble protein aggregates. A similar result was obtained when pathogenic
polyQ tracts were linked to the yeast prion protein Rnq1, demonstrating that polyQ sequences are generic inducers of
amyloidogenesis. In conclusion, long polyQ sequences are powerful molecular tools that allow the efficient production of
seeding-competent amyloid structures.
Citation: Goehler H, Dro¨ge A, Lurz R, Schnoegl S, Chernoff YO, et al. (2010) Pathogenic Polyglutamine Tracts Are Potent Inducers of Spontaneous Sup35 and
Rnq1 Amyloidogenesis. PLoS ONE 5(3): e9642. doi:10.1371/journal.pone.0009642
Editor: Mel B. Feany, Brigham and Women’s Hospital, Harvard Medical School, United States of America
Received October 30, 2009; Accepted February 17, 2010; Published March 10, 2010
Copyright:  2010 Goehler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from HDSA, DFG (WA1151/5-1) and BMBF (NGFN1/2 and NGFNplus 01GS08170 as well as the BioFuture project
0311853) to EEW. YOC was supported by grant R01GM58763 from the National Institutes of Health. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ewanker@mdc-berlin.de
¤a Current address: Protagen AG, Dortmund, Germany
¤b Current address: SINA Science Services GmbH, Teltow, Germany
Introduction
Amyloids are fibrillar, highly ordered protein aggregates with a
typical cross b-sheet structure [1]. They appear in cells as well as in
the extracellular space and are often associated with protein
misfolding disorders, including neurodegenerative diseases such as
Alzheimer’s disease, Huntington’s disease and prion disease [2,3].
Functionally, amyloids are involved in numerous physiological
processes such as information transfer in neurons, melanosome
biogenesis or modulation of translation termination [4]. Although
pathogenic and non-pathogenic amyloid assembly are pervasive
biological processes, we still lack a comprehensive understanding
of the molecular mechanisms that lead to the spontaneous
formation of amyloid.
There are striking similarities in the aggregation behaviour of
different amyloidogenic peptides and proteins [1]. In the initial
phase of amyloidogenesis, aggregation-prone monomers relatively
slowly form soluble oligomers [5]. These earliest aggregation
species, visible by electron and atomic force microscopy, are small
bead-like structures, also described as amorphous protein
aggregates [6]. Amyloidogenic oligomers are biochemically and
biophysically not very well defined and are currently thought
to cause cellular toxicity in numerous amyloid diseases [7]. Over
time, they transform into larger aggregate species with a more
fibrillar morphology, often termed ‘‘protofibrils’’ [8]. Protofibrils
are better defined with regard to size and biological activity and
are also highly toxic for mammalian cells [9]. Finally, protofibrils
self-assemble efficiently into large mature amyloid fibrils, perhaps
through association of monomers or oligomers, which is often
accompanied by a structural reorganisation of aggregates [1].
Currently, the molecular mechanisms behind the initiation of
amyloid self-assembly are largely unclear. On the one hand, it is
thought that oligomer formation is driven by relatively unspeci-
fic protein-protein interactions between monomers resulting in
undefined, disordered structures [10]. On the other hand,
experimental evidence showed the earliest detectable oligomer
species to be fairly distinctive structures, suggesting that they are
formed by specific protein-protein interactions [11]. In any case,
the process is slow and inefficient, with a significant entropic
barrier that is mainly controlled by the concentration of
monomers [12].
A wide range of factors has been reported to influence
spontaneous amyloid assembly [13]. Extrinsic factors are, e.g.,
the physico-chemical properties of the cellular environment
of polypeptide chains (pH, temperature, ionic strength, protein
concentration) or molecular chaperones inhibiting or promoting
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aggregation by directly binding to polypeptide chains [14].
Intrinsic factors are properties of polypeptides, such as charge,
hydrophobicity, patterns of polar and non-polar amino acids and
the ability to adopt specific secondary structures [15]. In the case
of globular proteins, the propensity to spontaneously form amyloid
structures is inversely related to the stability of their native states
[13]. A large number of proteins that assemble into amyloid,
however, are at least partially unfolded under physiological
conditions [16].
Experimental evidence has been provided that a high content of
the polar amino acids glutamine (Q) and asparagine (N) leads to an
increased tendency in proteins to spontaneously form amyloids,
implicated in human neurodegeneration and non-Mendelian
inheritance of prions in yeast [17]. Several neurodegenerative
diseases including Huntington’s disease and a variety of spinocer-
ebellar ataxias are caused by a pathogenic expansion of CAG
codons in disease genes leading to the production of proteins with
elongated polyglutamine (polyQ) tracts. These proteins form
inclusion bodies in affected neurons in patient brains that correlate
with disease progression and toxicity [2]. Pathogenic polyQ tracts
in the Huntington’s disease protein, huntingtin, have been shown
to stimulate the assembly of amyloid fibrils in vitro and in vivo
[18,19], suggesting a function as aggregation-promoting sequences
driving amyloidogenesis.
Glutamine/asparagine (Q/N)-rich regions are a characteristic
feature of the yeast prion proteins Sup35, Rnq1, Ure2 and Swi1
[17,20]. In these proteins, the Q/N-rich sequences, as part of
prion domains (PrDs), are critical for spontaneous self-assembly of
ordered amyloid fibrils and the appearance of defined yeast
phenotypes [21]. Previous studies have shown that prions with
Q/N-rich regions can facilitate the assembly of polyglutamine
aggregates in yeast cells [22]. Glutamine-rich sequences exist in a
wide range of proteins across numerous species, suggesting that
they have important physiological functions [23]. This is
supported by bioinformatic studies, indicating that glutamine-rich
domains in proteins are conserved and can undergo positive
selection [24]. More specifically, they have been implicated as
facilitators of protein complex formation [23], however, their
physiological roles are largely unclear.
The structural basis of polyQ-mediated protein aggregation is
believed to be the formation of ‘‘polar zippers’’, in which b-sheets are
stabilised by hydrogen bonds between polar amino acids [25]. Once
monomers are joined by hydrogen bonds and a significant number
of stable protein complexes, so-called seeds, have appeared, amyloid
fibrils are formed efficiently by a nucleation-dependent process [26].
Whether polar zipper formation involving Q/N-rich regions in
proteins is indeed critical for the initiation of amyloidogenesis,
however, is currently unknown. Interestingly, proteins with aggre-
gation-promoting Q/N-rich domains such as the yeast prion protein
Sup35 have a relatively low intrinsic propensity to self-assemble [27].
In yeast cells, insoluble Sup35 protein aggregates appear de novo at
very low frequency. Spontaneous formation of Sup35 aggregates
occurs efficiently only at high protein concentrations and is greatly
facilitated by the presence of preformed Q/N-rich, seeding-
competent nuclei derived from other proteins [28]. This suggests
that the aggregation-prone Q/N-rich PrD in the full-length protein
is not sufficient to promote spontaneous Sup35 aggregation.
In this study, we have investigated whether polyQ sequences
and their ability to form polar zippers can be employed to initiate
the amyloidogenesis of soluble Q/N-rich prion proteins such as
Sup35. Fusion proteins of Sup35 or its N-terminal PrD with polyQ
tracts of different lengths were produced in vitro and in vivo.
Subsequently, the spontaneous formation of stable protein
aggregates was analysed using biochemical as well as cell biological
methods. Our data indicate that only long, pathogenic polyQ
tracts ($54 glutamines) are potent inducers of Sup35 amyloid
polymerisation. PolyQ-stabilised Sup35 amyloids are permanently
maintained in yeast cells and form independently of the biological
activity of the yeast chaperone Hsp104 or other Q/N-rich yeast
prions. Similar results were obtained when polyQ-tagged fusions
of the prion protein Rnq1 were systematically analyzed in yeast
cells.
Results
Pathogenic PolyQ Tracts Stimulate the Self-Assembly of
Seeding-Competent PrD Fibrils In Vitro
First, we examined whether polyQ tracts of different lengths
influence the amyloidogenesis of the Sup35 PrD using an in vitro
aggregation assay. Formation of SDS-insoluble PrD aggregates
was quantified by filtration and immunoblotting [26]. Soluble
fusion proteins with an N-terminal maltose binding protein (MBP),
a Q/N-rich PrD of Sup35 (1-123 aa) and C-terminal huntingtin-
derived polyQ tracts with 19, 55 or 89 glutamines were produced
in E. coli and purified under native conditions by affinity
chromatography. The MBP-tag, which can be removed from
the fusion proteins by factor Xa cleavage, allows affinity
purification and increases the solubility of the fusions. In contrast,
the polyQ sequences at the C-terminus are thought to stimulate
amyloidogenesis of the Q/N-rich PrD fragments by polar zipper
formation. The PrD was previously shown to slowly form amyloid
in cell-free and cell-based assays [29,30].
To initiate spontaneous amyloid assembly, equal amounts of
fusion proteins MBP-PrD, -PrDQ19, -PrDQ55 and -PrDQ89
(Fig. 1A) were digested with factor Xa at 37uC and formation of
SDS-stable protein aggregates was monitored over time by filter
retardation assay (FRA). We observed that the proteins PrDQ55
and PrDQ89 efficiently form SDS-stable protein aggregates after
an incubation period of 2–6 h, while the proteins PrD and
PrDQ19 under the same conditions do not (Fig. 1B). This
indicates that long ($55 glutamines), but not short polyQ
sequences (19 glutamines) are potent inducers of PrD aggregation
in vitro. The time course analysis also revealed that the PrDQ89
protein aggregates faster than the PrDQ55 protein (Fig. 1B),
indicating that initiation of amyloidogenesis is polyQ-length
dependent.
To determine whether the SDS-stable polyQ-containing PrD
aggregates observed by FRA are fibrillar amyloids, aggregation
reactions were analysed by electron microscopy (Fig. 1C).
Numerous clusters of large fibrils with a length of 0.2–3 mm and
a diameter of about 10 nm were observed with the PrDQ89 or the
PrDQ55 fusion proteins, indicating that the long polyQ tracts
mediate the self-assembly of typical amyloid structures. In
comparison, such structures were not detected with the proteins
PrDQ19 and PrD (Fig. 1C). With these proteins, however, smaller,
mostly non-fibrillar particles of varying size and shape were
frequently observed, indicating that the proteins PrDQ19 and PrD
self-assemble into oligomeric structures under these conditions that
might be precursors of mature amyloids [31].
To investigate whether the insoluble PrD-polyQ protein
aggregates are seeding-competent structures that can stimulate
the amyloidogenesis of other soluble Q/N-rich proteins, an in vitro
seeding assay was established (Fig. 1D). The proteins MBP-PrD, -
PrDQ19, -PrDQ55 or -PrDQ89 were incubated together with
factor Xa and a soluble MBP-HisSup35 fusion protein; formation
of SDS-stable HisSup35 aggregates was monitored after incuba-
tion for 24 and 48 h at 37uC by FRA using a monoclonal anti-His
antibody. We found that the proteins PrDQ55 and PrDQ89,
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which efficiently form amyloid structures in vitro (Fig. 1B), promote
HisSup35 aggregation (Fig. 1E), while the proteins PrD and
PrDQ19, which are soluble under these conditions, do not. This
indicates that the SDS-stable amyloids formed by PrD-polyQ
fusions are seeding-competent structures that can stimulate the
polymerisation of soluble Sup35 protein with a homologous Q/N-
rich PrD domain.
As previous studies have demonstrated that the PrD in Sup35 is
critical for the self-assembly of amyloid fibrils [30], we also
examined whether a His-tagged N-terminally truncated Sup35
Figure 1. PrD-polyQ fusion proteins form seeding-competent amyloid structures in vitro. (A) Schematic representation of MBP fusion
proteins with polyQ tracts of different lengths. (B) Time-resolved analysis of polyQ-mediated aggregation of PrD fusions by FRA. SDS-resistant protein
aggregates retained on filter membranes were detected using an anti-Sup35 antibody. (C) Electron micrographs of polyQ-containing PrD protein
aggregates. MBP fusions were digested with factor Xa without agitation at 37uC for 24h, stained with 1% uranyl acetate and visualised using a Philips
CM100 transmission electron microscope. (D) Schematic description of an in vitro seeding assay. The formation of seeding-competent polyQ-
containing PrD protein aggregates after cleavage of MBP fusion proteins with factor Xa and the subsequent conversion of HisSup35 protein from the
soluble to the amyloidogenic state is shown. SDS-stable protein aggregates were monitored by FRA using specific antibodies. (E) Analysis of
HisSup35 aggregate formation by FRA. MBP-PrD-polyQ fusion proteins together with MBP-HisSup35 or MBP-HisCT were incubated with factor Xa at
37uC for 24 and 48 h. Aggregates retained on filter membranes were detected using anti-His and anti-Sup35 antibodies.
doi:10.1371/journal.pone.0009642.g001
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protein (HisCT, Fig. 1A) can be converted into SDS-stable
aggregates. As shown in Fig. 1E, the HisCT fragment (254–685 aa)
was not converted from the soluble into the aggregated state by
PrDQ89 amyloids, supporting previous studies that the N-terminal
Q/N-rich region in Sup35 is critical for aggregation [32,33].
Pathogenic PolyQ Tracts Initiate the Self-Assembly of
Seeding-Competent PrD and Sup35 Aggregates in the
Absence of Q/N-Rich Rnq1 Prions
To investigate whether polyQ tracts stimulate the self-assembly of
Q/N-rich amyloid structures in vivo, PrD-polyQ as well as Sup35-
polyQ fusion proteins (Fig. 2A) were expressed in the yeast strain
GT17 [psi2][pin2] [34]. In this strain, endogenous Sup35 is soluble
and spontaneous aggregation occurs with an extremely low fre-
quency. Previous studies have also demonstrated that the Q/N-rich
prion protein Rnq1 is soluble in GT17 cells. In its prion state, Rnq1,
however, is aggregated and promotes the polymerization of Sup35 as
well as of other polyQ-containing proteins [22,28]. Thus, our
experimental design was chosen to create unfavourable conditions for
spontaneous aggregation of Sup35 and PrD fusion proteins, in order
to be able to test the effect of polyQ domains on this process.
The formation of SDS-stable PrD-polyQ aggregates in GT17 cells
was analysed by FRA after 48 h of growth using anti-polyQ and
anti-Sup35 antibodies. Fig. 2B shows that the proteins PrDQ54 and
PrDQ92 spontaneously form SDS-stable protein aggregates, while
PrD and PrDQ19 do not, although expressed at similar levels (not
shown). This supports the in vitro results and indicates that preformed
Q/N-rich Rnq1 aggregates are not required for de novo amyloido-
genesis, when PrD fusions with long polyQ tracts are expressed.
Next, we examined full-length Sup35 proteins with polyQ tracts
for their ability to self-assemble into insoluble aggregates. The
proteins Sup35, Sup35Q19, Sup35Q54 and Sup35Q92 were
overproduced in GT17 cells; aggregation was monitored by FRA
(Fig. 2A and B). Full-length Sup35 fusions with pathogenic polyQ
sequences (Q54 and Q92) formed SDS-stable protein aggregates,
whereas no aggregates were observed with the proteins Sup35 and
Sup35Q19. While aggregates were detectable with PrDQ54 and
PrDQ92 already after 48 h, aggregates of full-length Sup35-polyQ
fusions were observed after 72 h, demonstrating that fusion proteins
containing shorter Sup35 fragments that include only PrD (aa
1-123) assemble faster than the full-length Sup35 fusions (aa 1-685).
The results obtained by filter assay were confirmed by immuno-
fluorescence microscopy (Fig. 2C). GT17 cells overexpressing
PrDQ54 or PrDQ92 contained large perinuclear inclusion bodies
(0.5–1 mm) with insoluble protein aggregates. No such structures
were observed in yeast cells overproducing PrDQ19 or PrD (not
shown). In the vast majority of PrDQ19 expressing cells,
fluorescence was diffusely distributed throughout the cytoplasm.
Similar results were obtained when yeast cells expressing Sup35-
polyQ fusions were analysed (Fig. 2C).
To investigate the morphology of Sup35-polyQ aggregates,
experiments with immunogold labelled antibodies were carried
out (Fig. 2D). Immunoelectron microscopy of Sup35Q54 express-
ing cells repeatedly revealed rows of gold particles, suggesting that
at least part of the insoluble Sup35-polyQ aggregates have a
fibrillar morphology in yeast.
Aggregates Formed of PrD- and Sup35-PolyQ Fusions
Are Seeding-Competent Structures That Stimulate
Endogenous Sup35 Amyloidogenesis In Vivo
We next investigated whether insoluble PrD- and Sup35-polyQ
protein aggregates formed in vivo are seeding-competent structures
Figure 2. PrD and Sup35 fusion proteins with pathogenic polyQ tracts form amyloid structures in vivo. (A) Schematic representation of
PrD- and Sup35-polyQ fusion proteins expressed in GT17 yeast cells. (B) Analysis of SDS-stable PrD and Sup35 protein aggregates with polyQ sequences
by FRA. Protein aggregates retained on filter membranes were detected using anti-Sup35 and anti-polyQ antisera. (C) Immunofluorescencemicrographs
of GT17 yeast cells expressing PrD- and Sup35-polyQ fusion proteins. Cells were fixed, permeabilised, and probedwith an anti-polyQ antibody and a Cy3-
conjugated anti-rabbit IgG. Nuclei were counterstained with Hoechst 33258. Scale bar, 1mm. (D) Electron micrographs of GT17 cells expressing a
Sup35Q54 fusion protein. Cells were immunogold labeled using an anti-polyQ antibody. A cytoplasmic inclusion body with aggregated Sup35Q54
protein was detected by immunogold staining. Rows of gold particles indicate the formation of Sup35Q54 fibrils.
doi:10.1371/journal.pone.0009642.g002
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that can convert endogenous Sup35 protein from the soluble to the
insoluble state. Previous studies have demonstrated that aggrega-
tion of endogenous Sup35 dramatically influences translation
fidelity and stimulates read-through of nonsense codons. This can
be monitored with a nonsense mutation in the ADE1 gene (ade 1-
14) that permits growth of yeast cells on medium lacking adenine
(SD-Ade) as a result of Sup35 aggregation [35,36]. In GT17 cells,
endogenous Sup35 protein is soluble; however, it might covert into
insoluble aggregates when seeding-competent PrD- or Sup35-
polyQ proteins are expressed.
Serial dilutions of GT17 yeast transformants expressing the
different PrD-polyQ fusions were spotted onto SD-Ade plates and
formation of ADE+ colonies was examined after an incubation
period of 5 days. We found that yeast cells overproducing the
proteins PrD or PrDQ19 only very rarely formed ADE+ colonies,
while PrDQ54 or PrDQ92 expressing cells formed such colonies
with high frequency (Fig. 3A). This indicates that the PrD-polyQ
protein aggregates that are observed after 48 h (Fig. 2B) are
seeding-competent structures that can promote the aggregation of
soluble, endogenous Sup35 protein.
A similar result was obtained when GT17 cells expressing full-
length Sup35-polyQ proteins were spotted onto SD-Ade selective
plates (Fig. 3A). However, formation of ADE+ colonies was slower
with Sup35Q54 or Sup35Q92 than with the PrDQ54 or PrDQ92
fusion proteins. This indicates that the rate of polyQ-mediated
aggregation of target proteins correlates with the rate of de novo
appearance of ADE+ colonies. The faster the PrD-polyQ protein
aggregates are formed in GT17 cells, the faster the endogenous
Sup35 protein is converted into the amyloidogenic state. The same
applies to the full-length Sup35-polyQ fusion proteins. The results
obtained with the spotting assay were confirmed in a plating assay
that allows a quantification of ADE+ conversion frequencies [37]
(Table 1).
Experimental evidence has been provided previously that
insoluble polyQ aggregates per se can promote Sup35 aggregation,
when both an N-terminal Sup35 and a polyQ fragment are co-
expressed in yeast cells [38]. We therefore also tested whether co-
expression of the proteins PrD/Sup35, PrD/Q52 and PrD/Q90
in GT17 cells initiates spontaneous aggregation of endogenous
Sup35. In PrD/Q90 expressing cells, we found that SDS-stable
Sup35 aggregates are formed (Fig. 3B), confirming previous studies
that polyQ aggregates in trans can stimulate Sup35 polymerization
[38]. In cells expressing the other combinations, no insoluble
aggregates were detected. Similar levels of expression of recom-
binant proteins were detected by SDS-PAGE and immunoblotting
(Fig. S1).
The results obtained by FRA were also confirmed when cells
were spotted onto SD+Ade and SD-Ade plates (Fig. 3C). How-
ever, our studies clearly demonstrate that polyQ sequences in trans
are less potent initiators of endogenous Sup35 aggregation than
polyQ sequences in cis. While ADE+ colonies were observed after
5 days on SD-Ade plates with cells expressing PrDQ54 or PrDQ92
fusions (Fig. 3A), they were only observed after 14 days with cells
co-expressing the proteins PrD/Q90 (Fig. 3C).
We also examined whether the ADE+ convertants that grow on
SD-Ade plates indeed contain aggregated, endogenous Sup35
protein. 10 ADE+ colonies from a Sup35Q54 expressing GT17
strain were randomly picked and analysed for insoluble Sup35
protein using a centrifugation assay [39]. In all cases, endogenous
Sup35 protein was detected in the pellet fraction, indicating that
formation of polyQ-containing protein aggregates converts endog-
enous Sup35 protein from the soluble to the aggregated state. A
representative centrifugation experiment is shown in Fig. 3D. The
randomly chosen ADE+ convertant strain contains aggregated
Sup35Q54 fusion protein (,90 kDa) as well as endogenous Sup35
protein (,75 kDa). The [PSI+][PIN+] control strain OT56 also
Figure 3. Formation of PrD- and Sup35-polyQ amyloids
stimulates endogenous Sup35 aggregation in yeast. (A)
Expression of polyQ-containing PrD and Sup35 fusion proteins in
[psi2][pin2] GT17 yeast cells induces the spontaneous appearance of
ADE+ colonies on SD-Ade plates. (B) Analysis of cell lysates of GT17 cells
co-expressing the proteins PrD/Sup35, PrD/Q52 or PrD/Q90 by FRA
using anti-Sup35 and anti-polyQ antisera. (C) Growth assays of
[psi2][pin2] GT17 cells co-expressing the proteins PrD/Sup35, PrD/Q52
or PrD/Q90 on SD-Ade plates. (D) Analysis of endogenous Sup35 and
Rnq1 protein aggregation in GT17 cells overexpressing Sup35Q54 by
centrifugation assays. Proteins were detected by Western blotting using
anti-Sup35 and anti-Rnq1 antibodies. P, pellet fraction; S, supernatant
fraction.
doi:10.1371/journal.pone.0009642.g003
Table 1. De novo appearance of ADE+ colonies.
Plasmid Protein Conversion rate Fold increase
pYex2T - 1.061025 1
pYex2T-PrD PrD 6.961025 7
pYex2T-PrDQ19 PrDQ19 1.661023 160
pYex2T-PrDQ54 PrDQ54 3.061022 3000
pYex2T-PrDQ92 PrDQ92 5.361022 5300
pYex2T-Sup35 Sup35 3.061025 3
pYex2T-Sup35Q19 Sup35Q19 3.061025 3
pYex2T-Sup35Q54 Sup35Q54 4.661023 460
pYex2T-Sup35Q92 Sup35Q92 5.961023 590
pYex2T-Q52 Q52 1.061025 1
pYex2T-Q83 Q83 1.061025 1
The frequency of appearance of ADE+ colonies was determined by plating
equal quantities of cells onto SD media with and without adenine. After
incubation at 30uC for 10 days conversion rates were determined by counting
and averaging the colonies obtained in 3–5 independent experiments.
doi:10.1371/journal.pone.0009642.t001
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contains aggregated endogenous Sup35 protein. However, the
protein was soluble in [psi2][pin2] GT17 cells. Similar results
were obtained when ADE+ convertants expressing the proteins
Sup35Q92, PrDQ54 or PrDQ92 were analysed by centrifugation
assays (data not shown).
Finally, using centrifugation assays we investigated whether
Sup35Q54 overexpression promotes the aggregation of endogenous
Rnq1, an aggregation-prone Q/N-rich prion protein [28,40],
which was shown previously to have the potential to stimulate
spontaneous Sup35 polymerization. We found that Rnq1 was
soluble in Sup35Q54 expressing as well as in GT17 [psi2][pin2]
control cells, while it was insoluble in [PSI+][PIN+] cells (Fig. 3D).
This indicates that production of Sup35-polyQ fusion proteins
efficiently stimulates endogenous Sup35 but not Rnq1 aggregation.
Spontaneous Aggregation of Sup35-PolyQ Proteins Is
Not Prevented in DHSP104 Cells
Previous studies have demonstrated that self-assembly of
seeding-competent Sup35 aggregates in vitro critically depends on
the activity of the molecular chaperone Hsp104 [35]. Therefore,
we investigated whether spontaneous polyQ-mediated Sup35
aggregation is influenced by loss of Hsp104 function.
Plasmids encoding the proteins Sup35Q54 or Sup35Q92 were
transformed into the yeast strain OT78 [psi2][pin2] lacking the
functional Hsp104 protein (DHSP104) and formation of SDS-
stable, insoluble protein aggregates was analysed by FRA. We
observed that the proteins Sup35Q54 or Sup35Q92 readily
formed insoluble aggregates in the absence of Hsp104 (Fig. 4A),
indicating that loss of Hsp104 activity does not prevent polyQ-
mediated Sup35 aggregation in vivo.
In a further experiment, OT78 cells expressing the proteins
Sup35Q54 or Sup35Q92 were spotted onto SD-Ade selective
plates. As shown in Fig. 4B, ADE+ yeast colonies were not
observed with the DHSP104 OT78 yeast strain, while such
colonies were readily detectable with the GT17 strain expressing a
functional Hsp104 protein (Fig.3A, data not shown). Thus, loss of
Hsp104 function does not prevent Sup35-polyQ amyloidogenesis
but seems to prevent endogenous Sup35 aggregation, which is
normally induced by Sup35Q54 and Sup35Q92 aggregates in
GT17 cells (Fig. 3A).
To investigate this result in more detail, OT78 and GT17 yeast
cells overexpressing the fusion protein Sup35Q54 were next
analyzed by centrifugation assays. We found that in OT78 cells a
small fraction of the proteins Sup35Q54 (,90 kDa) and
endogenous Sup35 (,75 kDa) is soluble, while both proteins are
completely insoluble in GT17 cells (Fig. 4C). This indicates that
deletion of the HSP104 gene increases the solubility of Sup35Q54
and endogenous Sup35 in OT78 cells. We suggest that the
appearance of soluble, functional Sup35 protein leads to improved
translation termination, which prevents the appearance of ADE+
colonies (Fig. 4B). In strong contrast, in GT17 cells, which
exclusively contain Sup35Q54 and Sup35 aggregates, a nonsense
suppression phenotype is observed.
Insoluble Sup35-PolyQ Aggregates Are Required for
Initiation of Sup35 Aggregation but Not for Prion
Propagation
To investigate whether insoluble Sup35-polyQ aggregates are
necessary for propagation of endogenous Sup35 aggregates, we
produced yeast cells that do not contain such structures. ADE+
GT17 cells harbouring episomal URA3 plasmids for the produc-
tion of Sup35Q54 or Sup35Q92 were plated onto 5-FOA selective
medium, and cells lacking the expression plasmids were selected
[41]. The resulting yeast cells were then analyzed by FRA whether
they contain insoluble Sup35-polyQ or Sup35 aggregates. We
observed that the 5-FOA selected yeast cells contain SDS-stable
Sup35 protein aggregates, while Sup35Q54 or Sup35Q92
aggregates were not detected (Fig. 5A). Spotting of 5-FOA treated
yeast cells onto SD-Ade and SD+Ade plates confirmed these
results (Fig. 5B). Yeast cells lacking Sup35-polyQ aggregates
formed ADE+ colonies on SD-Ade plates with similar frequency
than yeast strains expressing the proteins Sup35Q54 or Sup35Q92
(Fig. 5B, data not shown). Thus, the formation of Sup35Q54 or
Sup35Q92 aggregates is critical for the initiation of endogenous
Sup35 aggregation (Fig. 3A) but not for propagation of insoluble
Sup35 aggregates.
To study whether the insoluble Sup35 aggregates in 5-FOA
treated cells are efficiently passed on from mother to daughter
cells, we determined the frequency of formation of ADE+ colonies
on SD-Ade and SD+Ade plates after growing cells for many
generations (passage 1 and 2) on non-selective plates (Fig. 5C). We
observed that passage 1 and 2 cells formed ADE+ colonies with
the same frequency (,561022), indicating that the insoluble
Sup35 aggregates are stably propagated and efficiently passed on
from mother to daughter cells. These results were also confirmed
by centrifugation assay (Fig. 5D).
Finally, we investigated whether 5-FOA treated cells lacking
polyQ-containing Sup35 aggregates (P1 cells) can be cured of endo-
genous Sup35 aggregates by guanidine hydrochloride (GdnHCl)
treatment [42]. We found that P1 cells after GdnHCl treatment were
Figure 4. Loss of Hsp104 activity does not prevent the formation of Sup35-polyQ aggregates in yeast. (A) Analysis of Sup35Q54 and
Sup35Q92 aggregation in OT78 cells lacking a functional Hsp104 protein (DHsp104) by FRA. Protein aggregates retained on filter membranes were
detected using an anti-Sup35 antibody. Cell extracts prepared from GT17 cells containing a functional Hsp104 protein (control) were also examined.
(B) Growth assays of GT17 and OT78 cells expressing the proteins Sup35Q54 or Sup35Q92 on SD-Ade selective plates. (C) Analysis of Sup35Q54 and
endogenous Sup35 aggregation in GT17 and OT78 cells by centrifugation assay. Proteins were detected by Western blotting using an anti-Sup35
antibody. P, pellet fraction; S, supernatant fraction.
doi:10.1371/journal.pone.0009642.g004
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unable to grow on SD-Ade plates, while untreated cells efficiently
formed ADE+ colonies under such conditions (Fig. 5E, data not
shown). Thus, our data strongly indicate that polyQ-mediated Sup35
aggregation induces [PSI+] yeast prions, which can be cured by
GdnHCl treatement.
Pathogenic PolyQ Tracts Stimulate the Self-Assembly of
Insoluble, Seeding-Competent Rnq1 Protein Aggregates
To test whether polyQ sequences can be utilised more generally
to stimulate spontaneous amyloidogenesis of Q/N-rich proteins,
we fused such sequences of different lengths to the C-terminus of
the yeast protein Rnq1 [28,40]. Previous studies have demon-
strated that insoluble Rnq1 aggregates stimulate Sup35 amyloi-
dogenesis in yeast when both proteins are overproduced [28,34].
Thus, polyQ-mediated formation of Rnq1 aggregates in Sup35
overexpressing GT17 cells should stimulate Sup35 amyloidogen-
esis and induce the de novo appearance of ADE+ convertants
(Fig. 6A).
To test this hypothesis, expression plasmids encoding the fusion
proteins Rnq1Q19, Rnq1Q54 and Rnq1Q91 were constructed and
transformed into Sup35 overexpressing GT17 [pYex2T-Sup35]
cells (Fig. 6B). Formation of SDS-resistant protein aggregates was
Figure 5. Sup35-polyQ aggregates are not required for propagation of endogenous Sup35 aggregates. (A) Analysis of protein extracts
prepared from 5-FOA treated yeast cells by FRA. ADE+ GT17 cells expressing the proteins Sup35Q54 or Sup35Q92 were plated onto 5-FOA medium in
order to eliminate URA3 expression plasmids. SDS-stable aggregates retained on filter membranes were detected using anti-Sup35 and anti-polyQ
antibodies. (B) Growth assays of 5-FOA treated GT17 cells on SD-Ade plates. 5-FOA treated yeast cells showed growth on SD-Ade plates, indicating that
they contain insoluble, endogenous Sup35 aggregates. (C) Schematic representation of growth assays with 5-FOA treated yeast cells on different
selective plates. Yeast cells were grown for many generations on non-selective media in order to investigate the propagation of insoluble Sup35
aggregates. (D) Analysis of Sup35 aggregation in 5-FOA treated yeast cells lacking Sup35-polyQ fusion proteins (DSup35Q54 and DSup35Q92) by
centrifugation assays. P, pellet fraction; S, supernatant fraction. (E) GdnHCl treatment of 5-FOA treated yeast cells (P1) lacking the proteins Sup35Q54 and
Sup35Q92. After GdnHCl treatment P1 cells were unable to grow on SD-Ade plates, indicating that they do not contain insoluble Sup35 aggregates.
doi:10.1371/journal.pone.0009642.g005
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analysed by FRA (Fig. 6C). We observed that the proteins
Rnq1Q54 and Rnq1Q91 form SDS-stable aggregates in GT17
[pYex2T-Sup35] cells, while no aggregates were detected with the
proteins Rnq1 and Rnq1Q19. This supports the results obtained
with the PrD- and Sup35-polyQ fusion proteins and substantiates
the hypothesis that aggregtion-promoting polyQ tracts ($54
glutamines) induce the de novo aggregation of Q/N-rich proteins.
Strikingly, the filter assays revealed that cell extracts with insoluble
Rnq1Q54 or Rnq1Q91 aggregates also contained SDS-stable
Sup35 aggregates, indicating that formation of polyQ-tagged Rnq1
aggregates indeed stimulates the aggregation of Sup35, which
contains a heterologous Q/N-rich prion domain. Thus, polyQ-
mediated aggregation of one Q/N-rich protein can convert another
Q/N-rich protein from the soluble to the amyloidogenic state.
To confirm these results, growth assays were performed and
serial dilutions of yeast transformants were spotted onto SD-Ade
plates. As shown in Fig. 6D, cells overexpressing the proteins
Rnq1Q54 and Rnq1Q91 formed ADE+ colonies on SD-Ade
plates, while such colonies were only very rarely detected with
yeast cells overproducing the proteins Rnq1 or Rnq1Q19. These
data indicate that formation of polyQ-tagged Rnq1 protein
aggregates can stimulates Sup35 aggregation in yeast.
Discussion
In this study, we have systematically analysed the spontaneous
aggregation of hybrid fusion proteins with Q/N-rich PrDs and
polyQ sequences of different lengths using cell-free and cell-
based assays. We found that PrD and Sup35 fusions with long,
pathogenic polyQ tracts ($54 glutamines) efficiently self-assemble
into seeding-competent, SDS-stable protein aggregates, while
fusions with short, non-pathogenic polyQ tracts (19 glutamines)
or proteins without a polyQ tag do not. Moreover, we observed
that de novo amyloidogenesis of PrD- or Sup35-polyQ fusions is
largely independent of extrinsic factors such as other Q/N-rich
yeast prions, indicating that increasing the content of aggregation-
promoting sequences in proteins enhances their tendency to
spontaneously self-assemble into insoluble protein aggregates.
Why do long but not short polyQ tracts stimulate spontaneous
amyloidogenesis? Recent NMR studies revealed that long polyQ
tracts are structurally very similar to short polyQ tracts [43]. This
implies that both species should have similar biochemical and
biophysical properties and both should be able to stimulate
spontaneous amyloid assembly. We suggest that long polyQ
sequences are more potent initiators of de novo aggregation because
they can form hyperstable b-sheets in soluble proteins indepen-
dently of their folding state. These b-sheets, stabilised by hydrogen
bonds, are exposed on the protein surface. In this way, they might
be able to associate with b-sheets of long polyQ tracts in other
proteins and thereby could form stable aggregation-competent
protein complexes. In strong contrast, short polyQ sequences do
not form stable b-sheets in soluble proteins. Therefore, the
spontaneous assembly of amyloidogenic protein aggregates is
unlikely, and extrinsic factors such as molecular chaperones or
preformed b-sheet-rich aggregates are required to mediate
amyloid formation. Recent structural studies support the hypoth-
esis that short polyQ sequences in huntingtin do not form stable b-
sheets [44]. Instead, they are highly flexible and can adopt
multiple conformations, including b-helical, random coil and
extended loop structures.
Structural studies of polyQ-containing fibrillar aggregates suggest
that they consist of cylindrical b-sheets held together by hydrogen
bonds between the main chain and the side chain amides [25]. In
this model, one turn of b-sheets consists of 20 glutamine residues. It
Figure 6. Aggregates of Rnq1-polyQ fusion proteins stimulate the polymerization of endogenous Sup35 protein. (A) Cartoon
illustrating that formation of seeding-competent Rnq1-polyQ aggregates, which promote polymerization of endogenous Rnq1 and Sup35.
Spontaneous assembly of Sup35 protein aggregates is monitored by growth assays on SD-Ade plates. (B) Schematic representation of Rnq1-polyQ
fusion proteins. (C) Analysis of cell extracts prepared from yeast strains expressing polyQ-containing Rnq1 proteins by FRA. (D) Growth assays on SD-
Ade selective plates. GT17 [pYex2T-Sup35] yeast cells overexpressing the fusion proteins Rnq1Q54 or Rnq1Q91 form ADE+ colonies on SD-Ade plates.
doi:10.1371/journal.pone.0009642.g006
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is most likely unstable because it cannot be held together by
hydrogen bonds. In strong contrast, a b-sheet structure of two
helical turns (,40 glutamines) is much more stable because it is
joined together by hydrogen bonds between amides of successive
turns. This is coherent with our results that proteins with long polyQ
tracts ($54 glutamines) form stable amyloid structures much faster
than proteins with short a polyQ sequence (19 glutamines). At the
same time, a pathogenic threshold of,40 glutamines was observed
in a large number of polyQ diseases like Huntington’s disease or
spinocerebellar ataxias [45].
There have been several studies on long polyQ tracts and their
ability to form stable b-sheets in soluble protein molecules. Using
CD spectroscopy, Nagai et al. (2007) [46] e.g. have demonstrated
that proteins with polyQ tracts of 62 glutamines efficiently adopt a
b-sheet conformation, while such a structure was not observed
with polyQ tracts of 19 glutamines. Interestingly, these authors
also showed that b-sheet formation precedes spontaneous
aggregation, indicating that it is critical for initiation of protein
polymerization. Structural changes in proteins with long polyQ
tracts that mediate aggregation were also observed using
fluorescence resonance energy transfer (FRET) and conformation
specific anti-polyQ antibodies [47,48], supporting the results
obtained with CD spectroscopy.
Previous studies have demonstrated that the N-terminal Q/N-rich
PrD drives spontaneous Sup35 aggregation [49]. This process,
however, is slow and relatively inefficient, because the Q/N-rich
sequence in Sup35 is not easily accessible and needs to be unmasked
to allow b-sheet formation [50]. Extrinsic factors such as preformed
Q/N-rich protein aggregates with a high b-sheet content are required
to stimulate conformational changes in soluble Sup35, leading to
spontaneous polymerization of protein molecules [31]. Our results
indicate that C-terminal aggregation-prone polyQ tracts with
pathogenic lengths reduce the requirement for extrinsic stimulators
of Sup35 aggregation. Long polyQ tracts most likely form stable b-
sheets in proteins and thereby facilitate the association of soluble
protein molecules by polar zippers formation [25]. A model for
spontaneous polyQ-mediated Sup35 aggregation in comparison to
template-mediated Sup35 polymerization is shown in Fig. 7.
Biochemical and cell biological studies have demonstrated that
insoluble Q/N-rich Rnq1 as well as polyQ aggregates are able to
convert Sup35 from the soluble into the insoluble state, indicating
that template-mediated heterologous seeding is critical for
spontaneous Sup35 aggregation [28,34,38]. In our studies, we
could successfully confirm these results. However, we also
observed that long polyQ tracts fused to the C-terminus are more
potent initiators of Sup35 polymerization than performed
Figure 7. A model for polyQ- and template-mediated Sup35 aggregation in yeast. (A) PolyQ-mediated Sup35 aggregation converts
endogenous Sup35 from the soluble into the insoluble state. Soluble Sup35Q92 monomers are joined together by polyQ-mediated polar zipper
formation leading to the assembly of insoluble b-sheet-rich protein aggregates. These structures then function as templates for the polymerization of
endogenous Sup35 molecules. Sup35Q92-mediated Sup35 aggregation is triggered by the Q/N-rich PrDs present in both proteins. Sup35
aggregation is accompanied by conformational changes in the Q/N-rich PrD leading to the formation of aggregation-prone b-sheet-rich structures.
(B) Template-mediated Sup35 aggregation. Pre-existing b-sheet-rich Rnq1 aggregates with an accessible Q/N-rich PrD stimulate the aggregation of
soluble Sup35 molecules, which contain a related Q/N-rich PrD. Aggregation is accompanied by conformational changes in the Sup35 PrD leading to
b-sheet-rich structures.
doi:10.1371/journal.pone.0009642.g007
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heterogenous protein aggregates. This indicates that amyloid
templates with Q/N-rich domains in trans promote polymeriza-
tion of soluble Sup35 molecules less efficiently than aggregation-
prone polyQ sequences in cis.
We assume that polyQ-mediated polar zipper formation in
Sup35 fusion proteins leads to enhanced misfolding, protein
aggregation and an improved exposure of normally masked Q/N-
rich domains. These domains then can associate with homologous
domains in soluble Sup35 molecules, leading to conformational
changes and spontaneous self-assembly of Sup35 into insoluble
aggregates (Fig. 7A).
Our data indicate that polar amino acids of a certain length
($54 glutamines) are necessary for promoting Sup35 aggregation.
However, previous studies have demonstrated that short hydro-
phobic polypeptide sequences fused to the C-terminus are also
able to induce Sup35 polymerization [28,34]. Thus, besides long
polyQ tracts, hydrophobic protein domains also have potential
aggregation-promoting functions. However, more detailed studies
are necessary to address the mechanism of aggregation initiation of
non-polar amino acid sequences.
Our data indicate that the activity of the molecular chaperone
Hsp104 is not required for aggregation of Sup35 fusion proteins
with pathogenic polyQ tracts. SDS-stable Sup35Q54 aggregates
e.g., were readily observed in [pin2][psi2] cells in the absence of
Hsp104 (Fig. 4A), suggesting that endogenous Sup35 should also
be efficiently converted from the soluble into the aggregated state.
However, growth assays revealed that DHSP104 cells expressing
Sup35Q54 do not form ADE+ colonies on SD-Ade plates,
indicating that endogenous Sup35 remains soluble in these cells.
Analysis of cell extracts with centrifugation assays confirmed that
in cells lacking Hsp104 activity a small fraction of both Sup35Q54
and endogenous Sup35 remains soluble, indicating that Hsp104
function is critical for efficient aggregation of both proteins. These
data support previous studies demonstrating that Hsp104 catalyzes
the formation of new Sup35 polymers in vivo [51]. Thus, it seems
reasonable to speculate that Hsp104 maintains Sup35 aggregates
in [PSI+] cells not only by severing existing aggregates but also by
promoting the formation of new seeding-competent insoluble
structures [35,52,53].
Recent studies have demonstrated that the Q/N-rich sequence
in the PrD domain of Sup35 can be replaced by polyQ sequences
without impairing the ability of the protein to form aggregates
[49,54]. However, the polyQ-Sup35 hybrid proteins lacking the
Q/N-rich domain were not able to stimulate aggregation of
endogenous Sup35. This demonstrates that polyQ tracts do not
fully functionally replace Q/N-rich domains in yeast prions. In our
studies polyQ tracts were not utilized to substitute the aggregation-
promoting function of PrDs. Rather, we intended to examine the
spontaneous aggregation of artificial Sup35 fusion proteins
containing two potential aggregation-promoting domains such as
a Q/N-rich PrD and a polyQ tract.
A large number of neurodegenerative disorders including
Huntington’s disease are caused by the expansion of polyQ tracts
that drive aggregation of the affected proteins. Our data
demonstrate that pathogenic polyQ tracts are potent initiators of
amyloidogenesis, dramatically accelerating spontaneous protein
self-assembly. Pathogenic polyQ sequences are able to escape the
cellular control mechanisms and to act as seeding templates for
homologous as well as heterologous proteins. This means that the
disease proteins in polyQ disorders might also convert unrelated
proteins into amyloid structures. Therapeutic strategies for polyQ
diseases therefore need to focus on small molecules that target
pathogenic but not non-pathogenic polyQ sequences. Moreover,
they should not influence the normal function of glutamine-rich
proteins, which are commonly found in mammalian cells. Our
polyQ-mediated aggregation system in yeast could be very useful
for the identification of modulators that specifically influence the
self-assembly of disease-associated polyQ tracts and trigger
neurodegeneration in various diseases.
Materials and Methods
Yeast Strains
GT17 (MATa ade1-14 his3-D200 leu2-3,112 trp-289 ura3-52
[psi2][pin2]), OT56 (MATa ade1-14 his3-D200 leu2-3,112 trp-289
ura3-52 [PSI+][PIN+]) and OT78 (MATa ade1-14 his3-D200 leu2-
3,112 trp-289 ura3-52 hsp104D::LEU2 [psi2][pin2]) are derivatives
of the yeast strain 74D-694 [33,34,35].
Plasmids
For protein expression in Saccharomyces cerevisiae, the plasmids
pYex2T [55], pYex2T/L and pGADcup1 were used. pYex2T is a
pYEXbx-based 2m URA3 leu2-d vector (Clontech) containing a
copper inducible promoter. pYex2T/L was constructed from
pYex2T by deleting the 1.2 kb BstEII-KpnI fragment carrying the
leu2-d sequence. To subclone the promoter and the terminator of
pYex2T into pGAD426 (Clontech), a PCR fragment flanked by
SphI recognition sites was amplified using the primer pair P01/P02
(Table S1). Expression vector pGADcup1 was generated by
insertion of this fragment into the SphI site of pGAD426. To
generate the expression constructs pYex2T-PrD and pYex2T-
Sup35, the sequences encoding the PrD domain and full-length
Sup35 were PCR amplified using the primer pairs P03/P04 and
P03/P05 which carry XhoI und NotI recognition sites required for
cloning of the PCR products in pYex2T. Plasmids pYex2T-
PrDQ19, pYex2T-PrDQ54, pYex2T-PrDQ92, pYex2T-Sup35Q19,
pYex2T-Sup35Q54 and pYex2T-Sup35Q92 were constructed by
introducing htt exon 1 PCR fragments (P06/P07) obtained from
pCAG20, pCAG51 and pCAG122 [18] into the plasmids pYex2T-
PrD and pYex2T-Sup35 via NotI and EcoI restriction sites. In
addition, these PCR fragments were inserted into the NotI and EcoI
restriction sites of pYex2T to obtain pYex2T-Q19, pYex2T-Q54,
and pYex2T-Q92, respectively. To generate pGADcup1-PrD, a PrD
fragment flanked by BamHI and EcoRI restriction sites was isolated
from pYex2T-PrD and subcloned into pGADcup1. The plasmid
pMAL-c2X (Biolabs) was used for the expression of maltose-binding
protein (MBP) target protein fusions with a factor Xa cleavage site.
To generate pMAL-c2x-PrD and pMal-c2x-HisSup35, PCR frag-
ments were amplified from pYex2T-Sup35 using the primers P08/
P09 or P10/11 and inserted into the EcoRI and BamHI sites of pMAL-
c2X. Using the primer pair P12/13 PCR fragments were amplified
from pYex2T-Q19, pYex2T-Q54, and pYex2T-Q92, respectively,
and inserted into the PstI and HindIII recognition sites of pMAL-c2x
(Biolabs) to obtain the three expression plasmids pMAL-Q19, pMAL-
Q55 and pMAL-Q89. pMAL-c2X-HisCT was constructed by
inserting a DNA fragment encoding a C-terminal Sup35 (254-685
aa, HisCT) protein into the SalI/NotI site of pYex2T. The HisCT
fragment was generated by PCR amplification using pYex2T-Sup35
as template and primers P14/P05. To generate constructs for the
recombinant expression of PrDQ19, PrDQ55 and PrDQ89 in E.coli,
DNA fragments were amplified by PCR from the corresponding
pYex2T plasmids using the primers P08/P15, and inserted into the
EcoRI site of pMAL-c2X. The Rnq1 encoding reading frame was
PCR amplified from S. cerevisiae genomic DNA using the primers
P16/P17 and cloned into the SalI/NotI sites of pYex2T/L. To
construct expression plasmids encoding the Rnq-polyQ fusion
proteins, we first inserted htt exon 1 PCR fragments with 19, 54
and 91 CAG repeats into the NotI and EcoRI sites of pYex2T/L,
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thereby creating plasmid intermediates. Subsequently, a Rnq1
encoding PCR product amplified from pYex2T/L-Rnq1 with the
primers P16/P18 was inserted into the SalI/NotI sites of the inter-
mediate plasmids resulting in the plasmids pYex2T/L-Rnq1Q19,
pYex2T/L-Rnq1Q54 and pYex2T/L-Rnq1Q91. The sequences of
all primers are available online in Table S1.
Antibodies
The polyclonal antibodies anti-polyQ (anti-CAG53b), anti-
Sup35 and anti-Rnq1 have been described elsewhere [18,37,40];
the anti-His antibody was purchased from Qiagen.
Protein Expression and Purification
MBP-PrD,MBP-PrDQ19,MBP-PrDQ54,MBP-PrDQ89,MBP-
HisSup35, and MBP-HisCT were expressed in the E. coli strain
BL21-CodonPlus-RP (Stratagene). The cells were grown at 37uC to
an OD600 of 0.5 and then induced with 0.3 mM IPTG for 5 h at
30uC. Liquid cultures were harvested by centrifugation at 4,000 g for
20 min. Cell pellets were washed once with PBS and stored at
280uC. To purify the fusion proteins, frozen pellets were thawed on
ice, resuspended in 40 ml MBP-buffer [20 mM Tris-HCl pH 7.4,
200 mM NaCl, 5 mM MgCl2, EDTA-free protease inhibitor
(Roche)] containing 0.5 mg/ml lysozyme and incubated on ice for
30 min. Cell lysis was performed by sonication with a Branson B-450
sonifier (1 min, 100 W), and insoluble components were removed by
centrifugation (10,000 g, 30 min 4uC). Supernatants were trans-
ferred to 50 ml tubes and incubated with pre-washed amylose beads
(BioLabs) for 2 h at 4uC with rotation. Proteins bound to the affinity
matrix were packed to empty 10 ml columns (MoBiTec) and washed
three times with MBP-buffer. 1.5 ml fractions were eluted with
MBP-buffer containing 10 mM maltose and the resulting protein
solutions were dialysed against cleavage-buffer (20 mM Tris-HCl
pH 8.0, 100 mM NaCl, 8.7% glycerol). Aggregated material was
removed by ultracentrifugation (100,000 g, 20 min, 4uC) and
aliquots of the clarified protein solutions were frozen in liquid
nitrogen and stored at 280uC. Protein concentrations were
determined using a Bio-Rad protein assay (Biorad), purity of the
samples was monitored by SDS-PAGE and Coomassie staining.
In Vitro Filter Retardation Assay
For in vitro aggregation assays, purified fusion proteins were
subjected to ultracentrifugation (100,000 g, 20 min) to remove
aggregated material. Fusion proteins were diluted to a concentra-
tion of 200 ng/ml in digestion buffer [20 mM Tris-HCl, pH 8.0,
100 mM NaCl, 2 mM CaCl2] and treated with 0.9 mg of factor
Xa in a reaction volume of 90 ml. Samples were incubated at 37uC
without agitation. For time course experiments, samples were
collected after 0, 2, 4, 6, 8, 20 and 30 h, frozen in liquid nitrogen
and stored at 280uC. For further analysis, samples were
denatured for 5 min at 95uC in the presence of 2% SDS and
50 mM DTT. Subsequently, 20 ml aliquots were analysed by filter
retardation assay (FRA) as described [56]. Aggregated material on
filters was detected using anti-polyQ and anti-Sup35 specific
antisera. For seeding experiments, 100 ng/ml MBP-HisSup35 or
100 ng/ml MBP-HisSupCT were mixed with 1.4 mg factor Xa and
200 ng/ml of MBP-PrD, MBP-PrDQ19, MBP-PrDQ55 and
MBP-PrDQ89, respectively, in a final volume of 90 ml. Samples
were incubated for 0, 24, and 48 h before they were heat
denaturated and subjected to FRA as described above.
Culture Conditions
Unless noted otherwise, yeast strains were grown in complete
glucose medium (YPD) at 30uC. Selective media lacking adenine
and containing glucose as carbon source were used for selection of
ADE+ colonies. To remove URA3 plasmids from yeast cells, SD
medium supplemented with uracil and 500 mg/l 5-fluoroorotic
acid (5-FOA) was used [41]. For GdnHCl treatment, yeast
colonies were passaged three times on YPD plates containing
5 mM GdnHCl, transferred to YPD and then to SD-Ade medium
to assay the ade1-14 nonsense suppressor phenotype [57,58].
Transformants were grown on synthetic glucose media (SD)
selective for plasmid maintenance (e.g. SD-Ura).
Growth Assays
Single yeast colonies were inoculated in selective SD medium
and incubated over night at 30uC. The OD600 of cultures was
determined and used to adjust the cell densities to a uniform
concentration of 56107 cells/ml. To perform qualitative growth
assays, three dilutions (1:10, 1:100 and 1:1000) of yeast cultures
were prepared and spotted onto SD media supplemented with or
without adenine using a stamp. Subsequently cells were incubated
at 30uC for three to twelve days. To perform quantitative growth
assays, equal cell numbers were plated onto appropriate SD media
(SD-Ade and SD+Ade) and incubated at 30uC for 10 days. The
number of colonies was counted and the conversion frequencies
was determined by dividing the number of yeast colonies
appearing on SD-Ade plates (ADE+phenotype) by the number
of yeast colonies appearing on SD+Ade plates.
In Vivo Filter Retardation Assay
Yeast cells overexpressing polyQ-containing Sup35 proteins
were grown for 2–3 days in the appropriate selective media. For
each assay, ,56108 cells were harvested and washed with PBS.
Pellets were suspended in 300 ml of denaturation solution
containing 2% SDS and 50 mM DTT. After addition of 300 ml
glass beads, cell lysis was accomplished by three cycles of freeze-
thaw, each followed by 1 min of vigorous vortexing. Cell debris
was removed by centrifugation at 3,000 g and supernatants were
incubated with 100 U/ml Benzonase (Merck) on ice for 30 min.
Subsequently, samples were boiled for 5 min and analysed by
FRA using anti-polyQ, anti-Sup35 and anti-Rnq1 antisera.
Centrifugation Assays
High speed centrifugations were performed as described before
[39], with minor modifications. To prepare protein extracts, 50 ml
cultures of OT56, GT17 and GT17 cells expressing Sup35Q54
were grown in appropriate selective media for 24 h at 30uC. In
each case, 2.56108 cells were harvested and pellets were washed
once in PBS, frozen in liquid nitrogen and subsequently thawed at
50uC. Cells were resuspended in two volumes of UC buffer
[25 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl2, 5%
Glycerol, 1% Tween 20, 1 mM PMSF, EDTA-free protease
inhibitors (Roche)] and after addition of one volume of glass beads
disrupted by vortexing for 3 min at room temperature. Debris was
removed by centrifugation (1,000 g, 3 min). 100 ml of the
supernatants were subjected to ultra centrifugation (100,000 g,
30 min, 4uC) to precipitate aggregates. The pellets were
resuspended in 100 ml of UC buffer and 25 mg total protein was
analysed by SDS-PAGE and Western blotting using an anti-Sup35
antiserum.
Electron Microscopy
To study the formation of fibrillar structures in vitro, purifiedMBP-
fusion proteins were subjected to ultracentrifugation (100,000 g,
20 min, 4uC) in order to remove preformed aggregated material. To
initiate aggregation, 200 ng/ml MBP-fusion protein was digested
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with 0.9 mg of factor Xa (Biolabs) in a total volume of 90 ml digest-
buffer [20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 2 mM CaCl2] at
37uC for 24 h without agitation. For electron microscopy, samples
were adsorbed to carbon-coated copper and negatively stained with
1% uranyl acetate. Preparations were viewed using a Philips CM100
transmission electron microscope. To visualise Sup35-polyQ
aggregates in yeast cells, a single yeast colony was inoculated in
selective SD medium and grown for three days at 30uC. The culture
was diluted with YPD medium to an OD600 of 0.3 and then
incubated for 3 h at 30uC. The culture was supplemented with
0.25% glutaraldehyde and 2% formaldehyde, post-fixed with 1%
sodium periodate and embedded in LRWhite resin. 60 nm sections
were immunolabeled with a 1:400 dilution of anti-htt antibody,
followed by a 1:100 dilution of goat anti-rabbit IgG cross-linked to
10 nm gold particles (British BioCell). Preparations were viewed
using a Philips CM100 transmission electron microscope.
Immunofluorescence Microscopy
A single yeast colony was inoculated in selective SD medium
and grown for three days at 30uC. The culture was diluted with
YPD medium to an OD600 of 0.3 and then incubated for 3 h at
30uC. Cells were washed once with PBS, resuspended in PBS,
fixed with formaldehyde at a final concentration of 4% and
incubated for 1 h at room temperature. After two wash cycles with
PO-buffer [100 mMKH2PO4, 1.2 M Sorbitol, pH 7,5], cells were
resuspended in the same buffer supplemented with 40 mg/ml
Zymolyase 100 T (Seikagaku Corp.) and 10 mM ß-Mercaptoeth-
anol, and incubated for 30 min at 25uC. 15 ml of the sample were
transferred onto a poly-D-lysine coated slide and incubated at
room temperature for 5 min. The slide was then immersed in
220uC cold methanol for 6 min immediately followed by
incubation in 220uC cold acetone for 30 sec. The slides were
air-dried before the attached cells were rinsed with 2% BSA in
PBS for 1 h and incubated with anti-polyQ antibody (1:100
dilution in 2% BSA in PBS). Cells were washed ten times with 2%
BSA in PBS and then incubated with Cy3-conjugated anti-rabbit
IgG (1:1000 dilution in 2% BSA in PBS) in the dark for 1 h. The
nuclei were counterstained with Hoechst 33258 (0,2 ng/ml in
water) for 10 sec. Cells were viewed under the fluorescence
microscope Axioplan-2 (Zeiss).
Supporting Information
Figure S1 Western blot analysis of yeast cell extracts containing
recombinant proteins. GT17 [pin2][psi2] cells were co-transfect-
ed with either PrD/Q52 or PrD/Q90 and transformants were
grown for 3 days at 30uC. Cells were lysed and subjected to
SDS-PAGE using a modified buffer system previously described
(Scha¨gger H (2006) Tricine-SDS-PAGE. Nat. Protoc. 1: 16–22).
The expression levels of recombinant proteins were monitored by
immunoblotting using an anti-polyQ and an anti-PrD antibody.
The polyclonal rabbit anti-PrD antibody was raised against the
PrD domain (1-123 aa) of Sup35.
Found at: doi:10.1371/journal.pone.0009642.s001 (1.07 MB TIF)
Table S1 Primer pairs used in this study.
Found at: doi:10.1371/journal.pone.0009642.s002 (0.04 MB
DOC)
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